Login
$LUNG
$2.80 -$0.06 (2.1%) Live

$LUNG SEC Filings

Filed On Filing
05 Nov 2026 SCHEDULE 13G/A
03 Nov 2026 10-Q
27 Oct 2026 8-K: Results of Operations and Financial Condition

Redwood City, CA - October 27, 2026 – Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for lung disease, today reported financial results for the third quarter of 2026 ende...

03 Sep 2026 Form 4: French Glendon E. Iii, Director

Sold 41,882 shares ($94.7K)

03 Sep 2026 Form 4: Radhakrishnan Srikanth, Chief Science & Techn. Officer

Sold 14,245 shares ($32.2K)

03 Sep 2026 Form 4: Lehman David Aaron, General Counsel

Sold 14,334 shares ($32.4K)

03 Sep 2026 Form 4: Rose Geoffrey Beran, Chief Commercial Officer

Sold 7,879 shares ($17.8K)

13 Aug 2026 SCHEDULE 13G/A
04 Aug 2026 10-Q
29 Jul 2026 8-K: Results of Operations and Financial Condition

Redwood City, CA - July 29, 2026 – Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for lung disease, today reported financial results for the second quarter of 2026 ended ...

29 Jul 2026 SCHEDULE 13G/A
09 Jun 2026 Form 4: Burns Thomas William, Director

Received 40,000 shares as a grant or award

09 Jun 2026 Form 4: Ferrari Richard, Director

Received 40,000 shares as a grant or award

09 Jun 2026 Form 4: Florin Daniel P, Director

Received 40,000 shares as a grant or award

09 Jun 2026 Form 4: Melenikiotou Georgia, Director

Received 40,000 shares as a grant or award

09 Jun 2026 Form 4: Sullivan Tiffany, Director

Received 40,000 shares as a grant or award

09 Jun 2026 Form 4: Mead Dana G Jr., Director

Received 40,000 shares as a grant or award

04 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

On June 4, 2026, Pulmonx Corporation (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). A total of 32,645,270 shares of the Company’s common stock were present or represented by proxy at the Annual Meeti...

03 Jun 2026 Form 4: Radhakrishnan Srikanth, Chief Science &Techn. Officer

Sold 14,497 shares ($22.3K)

03 Jun 2026 Form 4: Lehman David Aaron, GENERAL COUNSEL

Sold 14,594 shares ($22.5K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support